Evonik Operations GmbH

Evonik Operations GmbH has been granted 578 US utility patents between 2020 and 2025, placing Evonik Operations GmbH at rank #796 across all assignees tracked by PlainPatent. This portfolio spans 136 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.0 claims per patent with primary concentration in C08G (MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS). As a Foreign Corporation, Evonik Operations GmbH is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 65.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2020 through 2025, with 578 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Evonik Operations GmbH's 16.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a diversified footprint across 100+ CPC subclasses spreads risk across many technology fronts. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Evonik Operations GmbH against peers pursuing similar technology classes.